S
Smith & Nephew SNATS Inc (SNN)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
$31.16
-0.85 (-2.67%)
Market Cap: $13.59B
Last updated: Nov 06, 2026 at 4:25 PM ET
Earnings
Performance (10Y)
Beat Rate
26%(5/19)Avg Surprise
-33.25%Upcoming Estimates
Period ending Sep 30, 2026
EPS Consensus$0.53
Range$0.53 - $0.53
1 analysts
EPS RevisionsNo revisions (7d)No revisions (30d)
EPS Estimate DriftChange to current
90d ago$0.00n/a
60d ago$0.00n/a
30d ago$0.530.0%
7d ago$0.530.0%
Current$0.53
Revenue Consensus
$1.6BRange$1.5B - $1.6B
3 analysts
Period ending Dec 31, 2026
EPS Consensus$1.69
Range$1.66 - $1.74
4 analysts
Revenue Consensus
$1.8BRange$1.7B - $1.9B
18 analysts
Last 12 of 39 reported quarters and 2 upcoming estimates
Dividends
Last ex-dividend: Oct 2, 2026
Dividend Metrics
Forward Yield2.55%
Forward Annual Dividend$0.79
FrequencySemi-Annual
Pay MonthsMay, Nov
Growth
3Y CAGR+1.44%
5Y CAGR+0.59%
Key Metrics
Technical Indicators Dashboard
Moving Averages
SMA 10$30.68
SMA 20$29.87
SMA 50$28.35
SMA 200$30.75
EMA 10$30.77
EMA 20$29.99
EMA 50$29.16
EMA 200$30.16
MACD
Line: 0.92Signal: 0.77Hist: 0.15
ADX
ADX: 29.2+DI: 41.4-DI: 22.5
Aroon & PSAR
Aroon Up96.0
Aroon DownN/A
PSAR$29.80
Bollinger Bands
Upper Band$32.46
Lower Band$27.29
%B Position1732%(Upper)
Band Width0.75
RSI (14-Day)
Neutral
61.5
Momentum Oscillators
Stoch %K75.4
Stoch %D76.7
Williams %R-46.0
ROC (10d)1.1%
Momentum0.33
CCI (20d)80.2
MFI (14d)67.1
Volatility Measures
ATR (14d)$0.78(2.5%)
StdDev (20d)1.29
Hist Vol41.0%(High)
Volume Flow
VWAP$31.04
OBV-18.6M
AD Line-484.6M
CMF (20d)0.203
Volume Metrics
Avg Vol (20d)1.5M
Vol Ratio1.3x
VWMA (20d)$30.26
Pivot Points
R3$34.04
R2$33.52
R1$32.77
Pivot Point$32.24
S1$31.49
S2$30.97
S3$30.21
Advanced Oscillators
TSI33.28
Ultimate Osc59.2
KST116.90
Financial Data
Related GNG Research
No research available
Be the first to write about SNN
News
SNN Valuation and Fair Value
- Forward P/E
- 12.2x
- EV/EBITDA
- 11.0x
- PEG
- 1.2x
- P/B
- 2.6x
SNN Profitability: Margins, ROIC and FCF
- Gross margin
- 68.4%
- Operating margin
- 14.5%
- Net margin
- 10.1%
- ROIC
- 8.0%
- ROE
- 11.8%
- FCF margin
- 26.2%
SNN Competitors
Sector: Healthcare
SNN Analyst Ratings
- Consensus
- Hold
- Analysts
- 6
- Strong Buy
- 1
- Buy
- 0
- Hold
- 5
- Sell
- 0
- Strong Sell
- 0
SNN Bull Case vs Bear Case
Bull case
- SNN converts 26.2% of revenue into free cash flow.
Bear case
- SNN beat EPS estimates in 0.0% of its last 8 reported quarters.
SNN Earnings: Beat Rate and Next Report
- Beat rate
- 0 of 8 quarters (0.0%)
- Average surprise
- -57.3%
- EPS estimate (fiscal period ending Sep 30, 2026)
- $0.53
- Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
- 0 up, 0 down
SNN Dividend
- Forward yield
- 2.5%
- 3Y DPS growth
- 1.4%
- 5Y DPS growth
- 0.6%
- Pay months
- May, Nov
SNN Earnings Call
The latest SNN earnings call transcript on file is labeled 2026Q2.
Read the 2026Q2 transcriptFrequently Asked Questions About SNN
When is SNN's next ex-dividend date?
SNN has not declared its next regular ex-dividend date yet. Its last ex-dividend date was Oct 2, 2026 ($0.312 per share). Over the last 12 months, SNN went ex-dividend in Mar and Oct.
What is SNN's current dividend yield?
Smith & Nephew SNATS Inc (SNN) has a forward dividend yield of 2.55%.
Does SNN pay dividends?
Yes, Smith & Nephew SNATS Inc pays dividends with a forward dividend yield of 2.55%.
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.